Skip to main content
Steven Bair, MD, Hematology, Aurora, CO

StevenMBairMD

Hematology Aurora, CO

Clinical Fellow in Hematology/Oncology at the Hospital of the University of Pennsylvania

Dr. Bair is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bair's full profile

Already have an account?

  • Office

    1665 Aurora Ct
    Aurora, CO 80045
    Phone+1 720-848-0000
    Fax+1 720-848-1786

Education & Training

  • University of Pennsylvania
    University of PennsylvaniaMSCE, Clinical Epidemiology, 2018 - 2020
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2017 - 2020
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2014 - 2017
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2014

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2020 - 2025
  • WY State Medical License
    WY State Medical License 2021 - 2025
  • PA State Medical License
    PA State Medical License 2014 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • The Myron F. Kanter and Lawrence J. Kanter Endowment Award (Cardiology) Case Western Reserve University School of Medicine, 2014
  • Alpha Omega Alpha Inductee Alpha Omega Alpha, 2014

Publications & Presentations

PubMed

Abstracts/Posters

  • Use of Bendamustine for Lymphodepletion before Tisagenlecleucel (anti-CD19 CAR T cells) for Aggressive B-Cell Lymphomas
    Steven M. Bair, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...
    Steven M. Bair, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • The Utility of FDG-PET in the Treatment of Hodgkin Lymphoma
    The Utility of FDG-PET in the Treatment of Hodgkin LymphomaNovember 6th, 2019

Professional Memberships